New hope for matrix metalloproteinase inhibitors in cancer therapy

Drug Discovery Today

Volumn 6, Issue 12, 2001, Pages 615-

  Brown, Peter D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MARIMASTAT; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PLACEBO; TANOMASTAT;

CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; EXTRACELLULAR MATRIX; HUMAN; LUNG SMALL CELL CANCER; MORTALITY; NOTE; RANDOMIZED CONTROLLED TRIAL;

EID: 0035368777     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(01)01845-1     Document Type: Note

References (3)

1. Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis
2. A randomised, double-blind, placebo-controlled study of marimastat in patients with inoperable gastric adenocarcinoma